IPHA
Innate Pharma·NASDAQ
--
--(--)
--
--(--)
3.38 / 10
Netural
Fund‑flow score is 6.76 (good), with small and medium investors net inflowing, but large blocks show outflows and overall trend is negative. Analyst consensus is a single Strong Buy, yet historical win rate is 0% and the stock has fallen 26.9% recently.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-12
InstitutionBTIG
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for IPHA?
- IPHA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.38/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
